- All sections
- C - Chemistrymetallurgy
- C12N - Microorganisms or enzymescompositions thereofpropagating, preserving, or maintaining microorganismsmutation or genetic engineeringculture media
- C12N 9/76 - TrypsinChymotrypsin
Patent holdings for IPC class C12N 9/76
Total number of patents in this class: 122
10-year publication summary
|
10
|
7
|
11
|
6
|
9
|
11
|
7
|
12
|
17
|
3
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Sanofi-Aventis Deutschland GmbH | 2601 |
5 |
| Enzymatica AB | 29 |
5 |
| Carnegie Mellon University | 1595 |
4 |
| Waters Technologies Corporation | 1767 |
4 |
| Merck Sharp & Dohme Corp. | 2186 |
3 |
| Novozymes A/S | 3350 |
3 |
| Vertex Pharmaceuticals Incorporated | 1612 |
3 |
| BioPharma Translationsinstitut Dessau Forschungs GmbH | 4 |
3 |
| Merck Millipore Ltd. | 39 |
3 |
| Pontis Biologics, Inc. | 5 |
3 |
| Nestec S.A. | 2612 |
2 |
| Amgen Inc. | 4304 |
2 |
| The Johns Hopkins University | 5777 |
2 |
| Burcon NutraScience (MB) Corp. | 136 |
2 |
| Guild Associates, Inc. | 31 |
2 |
| Ipsen Biopharm Limited | 325 |
2 |
| Tokyo University of Science Foundation | 414 |
2 |
| Guangdong Ocean University | 178 |
2 |
| Cytiva Sweden AB | 774 |
2 |
| Endsulin, Inc. | 7 |
2 |
| Other owners | 66 |